Monitoring communicable diseases throughout South Africa and the African continent
Communicable diseases outbreak, and epidemic monitoring and response
Collect, analyse and interpret relevant data on communicable diseases

NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES

The national institute for communicable diseases (NICD)

Is a resource of knowledge and expertise in regionally relevant communicable diseases to the South African Government, to SADC countries and the African continent.

The NICD offers a variety of training programmes in the different areas of public health, including Field Epidemiology Training.

The Communicable diseases communiqué is published on a monthly basis for the purpose of providing up-to-date information on communicable diseases in South Africa. 

Developing young scientists as drivers of growth and innovation is vital in South Africa. This Youth Month we showcase some of our budding scientists. 

Latest News

LATEST SCIENTIFIC PUBLICATIONS

Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016–2017
Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016–2017
Candida auris is an invasive healthcare-associated fungal pathogen. Cases of candidemia, defined as illness in patients with Candida cultured from blood, were detected through national laboratory-based surveillance in South Africa during 2016–2017. We identified viable isolates by using mass spectrometry and sequencing. Among 6,669 cases (5,876 with species identification) from 269 hospitals, 794 (14%) were caused by C. auris.
Rapid and focused maturation of a VRC01-class HIV broadly neutralizing antibody lineage involves both binding and accommodation of the N276-glycan
Rapid and focused maturation of a VRC01-class HIV broadly neutralizing antibody lineage involves both binding and accommodation of the N276-glycan
The VH1-2 restricted VRC01-class of antibodies targeting the HIV envelope CD4 binding site are a major focus of HIV vaccine strategies. However, a detailed analysis of VRC01-class antibody development has been limited by the rare nature of these responses during natural infection and the lack of longitudinal sampling of such responses. To inform vaccine strategies, we mapped the development of a VRC01-class antibody lineage (PCIN63) in the subtype C infected IAVI Protocol C neutralizer PC063.
Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012
Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012
The aims of this study were to determine the prevalence of risk factors associated with hepatocellular carcinoma (HCC) in black adult South Africans and to estimate the size of the associated risks
Previous
Next
Close Menu